TrialBlood cancer journal2014
The optimal use of PEG-asparaginase in relapsed ALL--lessons from the ALLR3 Clinical Trial.
A Masurekar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papertrialcites it
TrialBlood cancer journal2014
A Masurekar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.